Identification of apolipoprotein A-I as a "STOP" signal for myopia

被引:55
|
作者
Bertrand, Eric
Fritsch, Christine
Diether, Sigrid
Lambrou, George
Mueller, Dieter
Schaeffel, Frank
Schindler, Patrick
Schmid, Katrina L.
van Oostrum, Jan
Voshol, Hans
机构
[1] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland
[2] Univ Tubingen, Sect Neurobiol Eye, D-72076 Tubingen, Germany
[3] Queensland Univ Technol, Sch Optometry, Brisbane, Qld 4001, Australia
[4] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia
关键词
D O I
10.1074/mcp.M600073-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Good visual acuity requires that the axial length of the ocular globe is matched to the refractive power of the cornea and lens to focus the images of distant objects onto the retina. During the growth of the juvenile eye, this is achieved through the emmetropization process that adjusts the ocular axial length to compensate for the refractive changes that occur in the anterior segment. A failure of the emmetropization process can result in either excessive or insufficient axial growth, leading to myopia or hyperopia, respectively. Emmetropization is mainly regulated by the retina, which generates two opposite signals: "GO/GROW" signals to increase axial growth and "STOP" signals to block it. The presence of GO/GROW and STOP signals was investigated by a proteomics analysis of the retinas from chicken with experimental myopia and hyperopia. Of 18 differentially expressed proteins that were identified, five displayed an expression profile corresponding to GO/GROW signals, and two corresponded to STOP signals. Western blotting confirmed that apolipoprotein A-I (apoA-I) has the characteristics of a STOP signal both in the retina as well as in the fibrous sclera. In accordance with this,intraocular application of the peroxisome proliferator-activated receptor alpha agonist GW7647 resulted in up-regulation of apoA-I levels and in a significant reduction of experimental myopia. In conclusion, using a comprehensive functional proteomics analysis of chicken ocular growth models we identified targets for ocular growth control. The correlation of elevated apoA-I levels with reduced ocular axial growth points toward a functional relationship with the observed morphological changes of the eye.
引用
收藏
页码:2158 / 2166
页数:9
相关论文
共 50 条
  • [1] IDENTIFICATION OF APOLIPOPROTEIN A-I IN BALF AS A BIOMARKER OF SARCOIDOSIS
    Nukui, Yoshihisa
    Miyazaki, Yasunari
    Suhara, Kozo
    Okamoto, Tsukasa
    Furusawa, Haruhiko
    Inase, Naohiko
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2018, 35 (01) : 5 - 15
  • [2] Apolipoprotein A-I mimetic peptides Apolipoprotein A-I mimetic peptides
    M., G. Anantharamaiah
    Navab, Mohamad
    Reddy, Sreenivas T.
    Hama, Susan
    Hough, Greg
    Palgunachari, Mayakonda N.
    Chaddha, Manjula
    Dattal, Geeta
    Garber, David W.
    Fogelman, Alan M.
    UNDERSTANDING BIOLOGY USING PEPTIDES, 2006, : 329 - +
  • [3] An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I
    Navab, M
    Anantharamaiah, GM
    Fogelman, AM
    CIRCULATION RESEARCH, 2005, 97 (11) : 1085 - 1086
  • [4] Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles
    Sviridov, D
    Pyle, L
    Fidge, N
    BIOCHEMISTRY, 1996, 35 (01) : 189 - 196
  • [5] Identification of apolipoprotein A-I as a target of platelet tyrosine kinases
    Foehrkolb, Christine
    Vogel, Katrin
    Lochnit, Guenter
    Presek, Peter
    PLATELETS, 2024, 35 (01)
  • [6] Identification of apolipoprotein A-I in the α-globulin fraction of avian plasma
    Roman, Yannick
    Bed'Hom, Bertrand
    Guillot, Alain
    Levrier, Julie
    Chaste-Duvernoy, Daniel
    Bomsel-Demontoy, Marie-Claude
    Jalme, Michel Saint
    VETERINARY CLINICAL PATHOLOGY, 2009, 38 (02) : 206 - 212
  • [7] On the Aggregation of Apolipoprotein A-I
    Frankel, Rebecca
    Sparr, Emma
    Linse, Sara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [8] Pharmacology of apolipoprotein A-I
    Andersson, LO
    CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (04) : 225 - 228
  • [9] Apolipoprotein A-I and Cancer
    Zamanian-Daryoush, Maryam
    DiDonato, Joseph A.
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [10] Apolipoprotein A-I mimetics
    Reddy, Srinivasa T.
    Navab, Mohamad
    Anantharamaiah, Gattadahalli M.
    Fogelman, Alan M.
    CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (04) : 304 - 308